Morgan Jess S & CO Inc Amgen Inc Transaction History

Morgan Jess S & CO Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $3.71 Million - $4.25 Million	-18,669 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $458,503 - $537,192	2,160 Added 13.08%	18,669 $3.97 Million
Q2 2021 Nov 30, 2021	BUY	$233.58 - $259.14 $380,501 - $422,139	1,629 Added 10.95%	16,509 $4.02 Million
Q1 2021 Nov 30, 2021	BUY	$221.91 - $258.6 $89,873 - $104,733	405 Added 2.8%	14,880 $3.7 Million
Q4 2020 Nov 30, 2021	BUY	$216.38 - $257.67 $847,993 - $1.01 Million	3,919 Added 37.13%	14,475 $3.33 Million
Q3 2020 Nov 29, 2021	SELL	$234.65 - $260.95 $86,820 - $96,551	-370 Reduced 3.39%	10,556 $2.68 Million
Q2 2020 Nov 29, 2021	SELL	$197.81 - $242.74 $383,355 - $470,430	-1,938 Reduced 15.07%	10,926 $2.58 Million
Q1 2020 Nov 29, 2021	BUY	$182.24 - $241.7 $76,540 - $101,514	420 Added 3.38%	12,864 $2.61 Million
Q4 2019 Nov 19, 2021	BUY	$189.21 - $243.2 $2.35 Million - $3.03 Million	12,444 New	12,444 $3 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Morgan Jess S & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Morgan Jess S & CO Inc with notifications on news.